MED XL Inc   Report issue

For profit
Founded: Pointe-Claire Canada (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2011
NCT01394458
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (3)

ethanol (1 trial)

heparin (liquaemin) (1 trial)

sodium citrate (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3